画像は参考用です
AON6278
+BOMMOSFET N-CH 80V 34A/85A 8DFN
-
メーカーアルファ・アンド・オメガ・セミコンダクタ株式会社
-
メーカー品番 #AON6278
-
在庫状況7618
365 日間品質保証
7*24 日間の品質保証
90-時間単位のサービス保証
1日間のアフターサービス保証
仕様
| 属性 | 値 |
| Supplier | Alpha & Omega Semiconductor Inc. |
| Package | Tape & Reel (TR),Cut Tape (CT) |
| ProductStatus | Active |
| FETType | N-Channel |
| Technology | MOSFET (Metal Oxide) |
| DraintoSourceVoltage(Vdss) | 80 V |
| Current-ContinuousDrain(Id)@25°C | 34A (Ta), 85A (Tc) |
| DriveVoltage(MaxRdsOnMinRdsOn) | 6V, 10V |
| RdsOn(Max)@IdVgs | 3.3mOhm @ 20A, 10V |
| Vgs(th)(Max)@Id | 3.3V @ 250µA |
| GateCharge(Qg)(Max)@Vgs | 86 nC @ 10 V |
| Vgs(Max) | ±20V |
| InputCapacitance(Ciss)(Max)@Vds | 4646 pF @ 40 V |
| PowerDissipation(Max) | 7.4W (Ta), 208W (Tc) |
| OperatingTemperature | -55°C ~ 150°C (TJ) |
| MountingType | Surface Mount |
| SupplierDevicePackage | 8-DFN (5x6) |
概要
Description
AON6278 is an antisense oligonucleotide (AON) therapeutic candidate. Antisense therapies use short, chemically modified nucleic acids that bind a target mRNA to modulate gene expression.
- Mechanism: commonly a gapmer that recruits RNase H to degrade the target mRNA, or a steric blocker that prevents translation.
- Chemistry: typically a phosphorothioate backbone with 2'-modified sugars (e.g., MOE or LNA) to improve stability and affinity.
- Target/Indication: public details on the exact target and disease are not widely published; designed to downregulate a disease-relevant transcript.
- Status: publicly available information is limited; usually described as preclinical or early-stage.
- Considerations: delivery to tissues, off-target risk, and immunogenicity influence safety and pharmacokinetics.
In short: AON6278 reflects standard antisense design principles for gene silencing, with target and development status not broadly disclosed in public sources.
- Mechanism: commonly a gapmer that recruits RNase H to degrade the target mRNA, or a steric blocker that prevents translation.
- Chemistry: typically a phosphorothioate backbone with 2'-modified sugars (e.g., MOE or LNA) to improve stability and affinity.
- Target/Indication: public details on the exact target and disease are not widely published; designed to downregulate a disease-relevant transcript.
- Status: publicly available information is limited; usually described as preclinical or early-stage.
- Considerations: delivery to tissues, off-target risk, and immunogenicity influence safety and pharmacokinetics.
In short: AON6278 reflects standard antisense design principles for gene silencing, with target and development status not broadly disclosed in public sources.
Pinout
Pin count: 8 pins (SO-8 package).
Function: Dual N-channel enhancement-mode MOSFET in one package (two N-channel MOSFETs for power switching/half-bridge use).
Function: Dual N-channel enhancement-mode MOSFET in one package (two N-channel MOSFETs for power switching/half-bridge use).
Manufacturer
- Manufacturer: Alpha and Omega Semiconductor (AOS).
- What kind of company: AOS is a fabless semiconductor company that designs and markets power MOSFETs and analog/mixed-signal ICs for power-management applications.
- What kind of company: AOS is a fabless semiconductor company that designs and markets power MOSFETs and analog/mixed-signal ICs for power-management applications.
Package
Package type isn’t fixed by the AON6278 part number. Vendors may offer it in several MOSFET packages; common options include DPAK (TO-252) and D²PAK (TO-263). Check the specific supplier’s datasheet to confirm the exact package.
